Furthermore, extensive research endeavors are imperative to unravel the intricate regulatory network encompassing C2orf27A, miR-610, and NOX4, while also uncovering additional downstream targets that may play pivotal roles in GC progression. This evidence concerns the gene NOX4 and gastric cancer.